About Zydus Lifesciences Ltd 
Zydus Lifesciences Ltd
Large Cap
Pharmaceuticals & Drugs
Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited) is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain including innovating (research & development), manufacturing, marketing and selling of finished dosage human formulations (generics, branded generics and specialty formulations, including biosimilars and vaccines), Active Pharmaceutical Ingredients (APIs), animal healthcare products and consumer well
Company Coordinates 
Company Details
Zydus Corporate Park S No 536, Khoraj Sarkhej-Gandhinagar H/W Ahmedabad Gujarat : 382481
Registrar Details
Sharepro Services (India) Pvt Ltd, 13A/B 2nd Floor, Samitha Warehousing Complex, Behind Sakinaka Telephone Exchange, Andheri Kurla Road, Sakinaka, Andheri (East), Mumbai
Capital Structure 
Present Equity Capital
INR 100.62 Cr
Number of Shares
100.62 Cr
Face Value
INR 1.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
18-Mar-2024
100.62
100.62
-5970149
1
Buy Back of Shares
22-Jul-2022
101.22
101.22
-11538461
0
Buy Back of Shares
22-Jul-2022
101.22
101.22
-11538461
1
Buy Back of Shares
06-Oct-2015
102.37
102.37
818994080
1
Stock Split
06-Oct-2015
102.37
102.37
818994080
1
Stock Split
05-Apr-2010
20.47
102.37
68249507
5
Bonus
05-Apr-2010
20.47
102.37
68249507
5
Bonus
07-Feb-2009
13.65
68.25
10885305
5
Merger
07-Feb-2009
13.65
68.25
10885305
5
Merger
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 31 Schemes (6.32%)
FIIs
Held by 624 FIIs (7.53%)
Promoter with highest holding
Zydus Family Trust (pankaj R. Patel, Pritiben P. Patel And Sharvil P. Patel-trustees) (74.96%)
Highest Public shareholder
Llife Insurance Corporation Of India (3.53%)
Individual Investors Holdings
5.47%
Management
Designation
Remuneration
Pankaj R Patel
Chairman (Non-Executive)
16.0 lacs
Sharvil P Patel
Managing Director
26.25 cr
Mukesh M Patel
Director
48.0 lacs
Nitin Raojibhai Desai
Independent Director
43.0 lacs
Dharmishta N Rawal
Independent Director
45.0 lacs
Apurva S Diwanji
Independent Director
46.0 lacs
Ganesh N Nayak
Executive Director
12.0 cr
Bhadresh K Shah
Independent Director
46.0 lacs
Dhaval N Soni
Company Sec. & Compli. Officer
0
Akhil A. Monappa
Independent Director
12.0 lacs
Upasana Konidela.
Independent Director
12.0 lacs
Raw Materials Dashboard 
Raw Materials
Amount(Rs Cr)
% of RM Cost
Purchases of Finished Goods
362.7
0%
Purchases of Finished Goods
Finished Goods Dashboard 
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Pharmaceutical Products
6,207.00
95.60%
Other Operating Revenues - Export Incentives
169.30
2.61%
Other Operating Revenues - Miscellaneous Income
114.00
1.76%
Pharmaceutical Products
Pharmaceutical Products
Other Operating Revenues - Export Incentives
Other Operating Revenues - Export Incentives
Other Operating Revenues - Miscellaneous Income
Other Operating Revenues - Miscellaneous Income
Revenue and Profits:
Net Sales:
5,269 Cr
(Quarterly Results - Dec 2024)
Net Profit:
1,024 Cr
Pharmaceuticals & Drugs
INR 87,442 Cr (Large Cap)
19.00
33
0.36%
-0.11
19.63%
3.89